# A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function

> **NCT02105870** · NA · UNKNOWN · sponsor: **University of Melbourne** · enrollment: 40 (estimated)

## Conditions studied

- Myocardial Infarction
- Coronary Artery Disease

## Interventions

- **DRUG:** Abciximab

## Key facts

- **NCT ID:** NCT02105870
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02105870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02105870, "A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02105870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*